{"name":"FRESENIUS KABI USA","slug":"fresenius-kabi-usa","ticker":"","exchange":"","domain":"freseniuskabiusa.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharmaceuticals","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-12-31","label":"STIMUFEND Phase 3 readout (Primary Mediastinal Large B-Cell Lymphoma)","drug":"STIMUFEND","drugSlug":"pegfilgrastim-fpgk","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-09-30","label":"STIMUFEND Phase 2 readout (Renal Pelvis and Ureter Urothelial Carcinoma)","drug":"STIMUFEND","drugSlug":"pegfilgrastim-fpgk","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"IDACIO","genericName":"ADALIMUMAB-AACF","slug":"adalimumab-aacf","indication":"Other","status":"marketed"},{"name":"OTULFI","genericName":"USTEKINUMAB-AAUZ","slug":"ustekinumab-aauz","indication":"Other","status":"marketed"},{"name":"STIMUFEND","genericName":"PEGFILGRASTIM-FPGK","slug":"pegfilgrastim-fpgk","indication":"Other","status":"marketed"},{"name":"TYENNE","genericName":"TOCILIZUMAB-AAZG","slug":"tocilizumab-aazg","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"IDACIO","genericName":"ADALIMUMAB-AACF","slug":"adalimumab-aacf","phase":"marketed","mechanism":"","indications":[],"catalyst":""},{"name":"OTULFI","genericName":"USTEKINUMAB-AAUZ","slug":"ustekinumab-aauz","phase":"marketed","mechanism":"","indications":[],"catalyst":""},{"name":"STIMUFEND","genericName":"PEGFILGRASTIM-FPGK","slug":"pegfilgrastim-fpgk","phase":"marketed","mechanism":"","indications":[],"catalyst":""},{"name":"TYENNE","genericName":"TOCILIZUMAB-AAZG","slug":"tocilizumab-aazg","phase":"marketed","mechanism":"","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":4,"phaseCounts":{"marketed":4},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}